It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
This study uses artificial intelligence for testing (1) whether the comorbidity of diabetes and its comorbid condition is very strong in the middle-aged or old (hypothesis 1) and (2) whether major determinants of the comorbidity are similar for different pairs of diabetes and its comorbid condition (hypothesis 2). Three pairs are considered, diabetes-cancer, diabetes-heart disease and diabetes-mental disease. Data came from the Korean Longitudinal Study of Ageing (2016–2018), with 5527 participants aged 56 or more. The evaluation of the hypotheses were based on (1) whether diabetes and its comorbid condition in 2016 were top-5 determinants of the comorbidity in 2018 (hypothesis 1) and (2) whether top-10 determinants of the comorbidity in 2018 were similar for different pairs of diabetes and its comorbid condition (hypothesis 2). Based on random forest variable importance, diabetes and its comorbid condition in 2016 were top-2 determinants of the comorbidity in 2018. Top-10 determinants of the comorbidity in 2018 were the same for different pairs of diabetes and its comorbid condition: body mass index, income, age, life satisfaction—health, life satisfaction—economic, life satisfaction—overall, subjective health and children alive in 2016. In terms of SHAP values, the probability of the comorbidity is expected to decrease by 0.02–0.03 in case life satisfaction overall is included to the model. This study supports the two hypotheses, highlighting the importance of preventive measures for body mass index, socioeconomic status, life satisfaction and family support to manage diabetes and its comorbid condition.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Graduate School of Korea University, Department of Public Health Sciences, Seoul, South Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678); Graduate School of Korea University, Interdisciplinary Program in Precision Public Health, Department of Public Health Sciences, Seoul, South Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678)
2 AI Center, Korea University College of Medicine, Seoul, Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678); Korea University, School of Health & Environmental Science, Seoul, Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678)
3 Korea University College of Medicine, Department of Obstetrics and Gynecology, Seoul, Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678)
4 AI Center, Korea University College of Medicine, Seoul, Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678)